DSD-T444

Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T444

DSD-T444 · Congenital adrenal hyperplasia (CAH) · 2025 · Automated translation

Genes CYP21A2 · Karyotype 46,XX · Phenotypes HPO:0000062, HPO:0004322, Ambiguous genitalia (HP:0000062), Short stature (HP:0004322)

Classic 11β-hydroxylase deficiency (46,XX DSD), previously misdiagnosed as 21-hydroxylase deficiency.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Karyotype

46,XX

Genetics

CYP21A2

Phenotypes

Ambiguous genitalia (HP:0000062); Short stature (HP:0004322)

Diagnosis

Classic 11β-hydroxylase deficiency (46,XX DSD), previously misdiagnosed as 21-hydroxylase deficiency.

Follow-up

Spontaneous conception, no pregnancy complications such as gestational diabetes, full-term spontaneous delivery of a healthy male infant.

General phenotype

Female phenotype, virilized external genitalia (Prader stage III), hypertension, hypokalemia.

Imaging

Pelvic ultrasound showed a normal uterus; no adrenal hyperplasia seen.

Laboratory findings

17OHP 28.7 nmol/L (0.6–3.9), 11-deoxycortisol 41.5 nmol/L (<3.1), testosterone 12.1 nmol/L (0.7–2.8), cortisol 109 nmol/L, DHEAS 0.49 μmol/L, serum potassium 3.0 mEq/L.

Management

Hydrocortisone and fludrocortisone replacement; clitoral reduction plus vaginoplasty at 6 months; after diagnosis switched to dexamethasone, and during pregnancy to prednisolone 7.5 mg/d.

Pathology

Not reported in the original

Evidence level

See source

Clinical history

See source

Growth and development

See source

Limitations

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · 46,XX · DSD-T444 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T444?version=v1.4.0